Crossmark

Erenumab punktet gegenüber Topiramat

Crossref DOI link: https://doi.org/10.1007/s15005-023-3206-y

Published Online: 2023-03-20

Published Print: 2023-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Özgör, Lamia
License Information

Text and Data Mining valid from 2023-03-01

Version of Record valid from 2023-03-01
More Information

Article History

First Online: 20 March 2023

Free to read: This content has been made available to all.